Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-01-22
2008-01-22
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S450000, C540S451000, C540S456000, C540S468000, C548S182000
Reexamination Certificate
active
11389665
ABSTRACT:
The present invention is directed to synthetic cytoskeletal active compounds that are related to natural Latrunculin A or Latrunculin B. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carrier. The invention is additionally directed to a method of preventing or treating diseases or conditions associated with actin polymerization. In one embodiment of the invention, the method treats increased intraocular pressure, such as primary open-angle glaucoma. The method comprises administering to a subject a therapeutically effective amount of a cytoskeletal active compound of Formula I or II, wherein said amount is effective to influence the cytoskeleton, for example by inhibiting actin polymerization.
REFERENCES:
patent: 4857538 (1989-08-01), Kashman et al.
patent: 5798380 (1998-08-01), Kaufman et al.
patent: 6110912 (2000-08-01), Kaufman et al.
patent: 6586425 (2003-07-01), Kaufman et al.
patent: 2002/0045585 (2002-04-01), Kaufman et al.
patent: WO97/30701 (1997-08-01), None
CA Registry No. 122877-01-4, entry date into Registry file on STN Sep. 29, 1989.
CA Registry No. 122898-81-1, entry date into Registry file on STN Sep. 29, 1989.
Blasberger, Dina et al, “On the chemistry of latrunculins A and B,” Liebigs Annalen Der Chemie, 1989, (12), pp. 1171-1188.
A. Fürstner et al.,Angew. Chem. Int. Ed. 2003, 42, 5358-5360.
A. Fürstner et al.,Proc. Natl. Acad. Sci. 2005, 102, 8103-8108.
A.B. Smith III et al.,J. Am. Chem. Soc. 1992, 114, 2995-3007.
J.D. White and M. Kawasaki,J. Org. Chem. 1992, 57, 5292-5300.
Blasberger, Dina et al., “On the chemistry of latrunculins A and B”, Liebigs Annalen Der Chemie, 1989, (12), 1171-88.
Fuerstner, Alois et al., “Concise and practical synthesis of latrunculin A by ring-closing enyne-yne metathesis”, Angewandte Chemie, International Edition, 2005, 44 (22), 3462-3466.
Crimmins Michael T.
Lampe John W.
Plourde, Jr. Robert
She Jin
Slade David J.
Coppins Janet L
Howrey LLP
Inspire Pharmaceuticals Inc.
Kung Viola T.
Saeed Kamal A.
LandOfFree
Cytoskeletal active compounds, compositions and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytoskeletal active compounds, compositions and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytoskeletal active compounds, compositions and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3913540